Clinical Trials for PX-866

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPHI1231
11/19/2012
Phase 1/2 Study of PI-3K Inhibition with PX-866 Combined with Vemurafenib (BRAF Inhibitor) in Patients with BRAF-Mutant Cancer Including Advanced Melanoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.